The Value of Serum MicroRNA-21-5p and LncRNAgadd7 Expression Levels in Predicting the Severity and Prognosis of ARDS ( Acute Respiratory Distress Syndrome )

Shao Yuekai110 enrolled

Overview

By measuring the expression levels of MicroRNA-21-5p (miR-21-5p) and LncRNAgadd7 in the peripheral blood of ARDS patients, the study aims to explore the correlation between these levels and the severity and prognosis of ARDS.

Study Type

OBSERVATIONAL

Enrollment

110

Conditions

Acute Respiratory Distress Syndrome

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Age ≥ 18 years; 2. Meets the Berlin Criteria for ARDS; 3. Diagnosed with ARDS within 48 hours; 4. Signed informed consent. Exclusion Criteria: 1. Immunosuppressed patients: including those on immunosuppressive drugs, history of stem cell transplantation, etc.; 2. Patients with malignant tumors; 3. Pregnant women; 4. Patients discharged from the ICU within 48 hours; 5. History of chronic lung diseases.

Locations (1)

Affiliated Hospital of Zunyi Medical University

Zunyi, Guizhou, China

Outcomes

Primary Outcomes

The expression levels of MicroRNA-21-5p (miR-21-5p)

Time frame: 28 days

the expression levels of LncRNAgadd7

Time frame: 28 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.